University of Colorado Cancer Center
Playback speed
10 seconds
Brain Mets & CNS Coverage of MET Signaling in NSCLC: Alectinib vs. Crizotinib, Unmet Need in ROS1, TKI Resistance
By
University of Colorado Cancer Center
FEATURING
Tejas Patil
By
University of Colorado Cancer Center
FEATURING
Tejas Patil
96 views
June 11, 2021
Comments 0
Login to view comments.
Click here to Login
Oncology Grand Rounds